Item 1.02 Termination of a Material Definitive Agreement.
BRRX Clinical Joint Venture Termination
On June 15, 2020 the Company entered into a settlement agreement with Bareroots RX, Inc., terminating the joint venture called BRRX Clinical, Inc. As a condition of the termination, which expressly incorporates no admission of liability, the Company received $95,689 and the return of all the stock issued (2,000,000 shares of MCIG common stock) as a part of the settlement.
It looks like it didn't cost either side anything but their time. If you'd been paying attention you would have seen that I've posted this info several times already. So your statement...
I'll make the statement now that the MCIG agreement with Bareroots RX ended in a lawsuit.